45 filings
Page 2 of 3
8-K
q8z71y4d v7f
6 Jun 19
Other Events
12:34pm
8-K
7itwbc3cw5f55r2
21 May 19
Other Events
4:34pm
8-K
xq5qq 9dvi
20 May 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K
s343mceh
15 May 19
Report of Independent Registered Public Accounting Firm
5:06pm
8-K/A
51wi1qg 8482u9sp
3 May 19
Other Events
5:00pm
8-K
1pcjj
2 May 19
Entry into a Material Definitive Agreement
12:00am
8-K
r65td
29 Apr 19
Other Events
3:36pm
8-K
5ufsdv8
4 Apr 19
Entry into a Material Definitive Agreement
7:00am
8-K
o6m8cgj1yis6kw
22 Mar 19
Entry into a Material Definitive Agreement
6:30am
8-K
ca25jk 2yhwl
20 Mar 19
Regulation FD Disclosure
2:40pm
8-K
3f0ly68
18 Mar 19
Xynomic Pharma Achieves Important Regulatory Milestones in China and EU in Potentially Pivotal Kidney Cancer and Lymphoma Trials
7:00am
8-K
orxh14sgell7g3j
4 Mar 19
Other Events
7:02am
8-K
6sejrrzq z35o
27 Feb 19
Entry into a Material Definitive Agreement
8:00am
8-K
lbbgi kts
12 Feb 19
Entry into a Material Definitive Agreement
11:08am
8-K
zca27
14 Jan 19
Bison Capital Acquisition Corp. & Xynomic Pharmaceuticals, Inc. Investor Presentation January 2019
12:00am
8-K
a88xv nufijaz4z
28 Dec 18
Submission of Matters to a Vote of Security Holders
9:44am
8-K
hl0s e8yeeunlt
18 Oct 18
Clarifies Information of Its Chairman and President
5:27pm
8-K
nj41exxk70tpr lzwl
19 Sep 18
Bison Capital Acquisition Corp. & Xynomic Pharmaceuticals, Inc. Investor Presentation September 2018
8:33am
8-K
ntzpnba
13 Sep 18
Announce Signing of Definitive Merger Agreement
12:00am
8-K
nfp7dltc
31 May 18
Departure of Directors or Certain Officers
11:32am